{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2010"],"condition":["Colorectal Cancer","Colorectal Neoplasms"],"disease":["Colorectal Cancer","Colorectal Neoplasms"],"study_type":["Interventional"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2094455"],"location":["China"],"study_start_month":["8"],"keyword":["5-fluorouracil","Chemotherapy","Advanced colorectal cancer","S-1","Levoleucovorin","Leucovorin","Elderly patients","Fluorouracil"],"repository":["ECRIN MDR"],"study_status":["Not provided"],"additional_accession":[]},"is_claimable":false,"name":"S-1/Leucovorin (SL) Versus sLV5FU2 as the First-line Treatment for Elderly Patients With Colorectal Cancer","description":"This phase II trial on the assumption that S-1 combined with Leucovorin may have better efficacy and safety than simplified 5-FU/LV infusion therapy in elderly patients with advanced colorectal cancer.","dates":{"creation":"2010-08-15"},"accession":"2094455","cross_references":{"ClinicalTrials___gov":["NCT01193452"]}}